# Heparin Versus Normal Saline in Peripherally Inserted Central Catheter Lines

> **NCT05029596** · EARLY_PHASE1 · COMPLETED · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 142 (actual)

## Conditions studied

- Cancer

## Interventions

- **DRUG:** Normal Saline Group
- **DRUG:** Heparin Group

## Key facts

- **NCT ID:** NCT05029596
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** EARLY_PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-02-12
- **Primary completion:** 2023-03-30
- **Final completion:** 2023-03-30
- **Target enrollment:** 142 (ACTUAL)
- **Last updated:** 2023-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05029596

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05029596, "Heparin Versus Normal Saline in Peripherally Inserted Central Catheter Lines". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05029596. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*